Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features

Background: Carcinoma of the esophagus poses a considerable medical and public health challenge in many parts of the world. Despite advances in screening and multimodal management of this disease, overall survival remains poor. There is an utmost need to find a marker for the establishment of target...

Full description

Saved in:
Bibliographic Details
Main Authors: Tarunpreet Saini, Manisha Sharma
Format: Article
Language:English
Published: Association of Clinical Pathologists of Nepal 2024-10-01
Series:Journal of Pathology of Nepal
Subjects:
Online Access:https://www.nepjol.info/index.php/JPN/article/view/56916
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849230262435577856
author Tarunpreet Saini
Manisha Sharma
author_facet Tarunpreet Saini
Manisha Sharma
author_sort Tarunpreet Saini
collection DOAJ
description Background: Carcinoma of the esophagus poses a considerable medical and public health challenge in many parts of the world. Despite advances in screening and multimodal management of this disease, overall survival remains poor. There is an utmost need to find a marker for the establishment of targeted immunotherapy. One immunohistochemical marker that has surfaced with the advent of anti-PDL1 immunotherapy is PD-L1 which has been proven to be advantageous. This study aimed to determine PD-L1 expression and its correlation with the grade of tumor and other histopathological parameters in 50 patients. Materials and Methods: A cross-sectional study was conducted on 50 cases of histopathologically proven esophageal carcinoma. Antibody used for PD-L1 was rabbit monoclonal (CAL10) Biocare. PD-L1 expression was considered positive when a complete or partial membranous or cytoplasmic staining pattern was noted in more than 5% of tumor cells. Correlation between PD-L1 expression and clinicopathological parameters was calculated. Proper consent was taken. The findings of the study were statistically analyzed using Statistical Package for the Social Sciences (SPSS) software version 21.0, a statistical program for Microsoft Windows. Results: This study revealed that PD-L1 positivity increases as the histopathological grade of esophageal squamous cells increases. Conclusions: The expression of PD-L1 increases with grade and shows more positive expression in poorly differentiated tumors. This indicates that PD-L1 overexpression is associated with aggressive disease. Targeted therapy against PD-L1 may prove to be beneficial in such patients.
format Article
id doaj-art-d5c09db8a8574c12bf6860247a15ce4b
institution Kabale University
issn 2091-0797
2091-0908
language English
publishDate 2024-10-01
publisher Association of Clinical Pathologists of Nepal
record_format Article
series Journal of Pathology of Nepal
spelling doaj-art-d5c09db8a8574c12bf6860247a15ce4b2025-08-21T06:55:17ZengAssociation of Clinical Pathologists of NepalJournal of Pathology of Nepal2091-07972091-09082024-10-011412138214210.3126/jpn.v14i1.5691684016Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological featuresTarunpreet Saini0https://orcid.org/0000-0001-5428-1870Manisha Sharma1https://orcid.org/0000-0002-9677-4873MD, PDF (Cytopathology)MDBackground: Carcinoma of the esophagus poses a considerable medical and public health challenge in many parts of the world. Despite advances in screening and multimodal management of this disease, overall survival remains poor. There is an utmost need to find a marker for the establishment of targeted immunotherapy. One immunohistochemical marker that has surfaced with the advent of anti-PDL1 immunotherapy is PD-L1 which has been proven to be advantageous. This study aimed to determine PD-L1 expression and its correlation with the grade of tumor and other histopathological parameters in 50 patients. Materials and Methods: A cross-sectional study was conducted on 50 cases of histopathologically proven esophageal carcinoma. Antibody used for PD-L1 was rabbit monoclonal (CAL10) Biocare. PD-L1 expression was considered positive when a complete or partial membranous or cytoplasmic staining pattern was noted in more than 5% of tumor cells. Correlation between PD-L1 expression and clinicopathological parameters was calculated. Proper consent was taken. The findings of the study were statistically analyzed using Statistical Package for the Social Sciences (SPSS) software version 21.0, a statistical program for Microsoft Windows. Results: This study revealed that PD-L1 positivity increases as the histopathological grade of esophageal squamous cells increases. Conclusions: The expression of PD-L1 increases with grade and shows more positive expression in poorly differentiated tumors. This indicates that PD-L1 overexpression is associated with aggressive disease. Targeted therapy against PD-L1 may prove to be beneficial in such patients.https://www.nepjol.info/index.php/JPN/article/view/56916esophageal carcinomaimmunohistochemistryimmunotherapypd-l1
spellingShingle Tarunpreet Saini
Manisha Sharma
Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
Journal of Pathology of Nepal
esophageal carcinoma
immunohistochemistry
immunotherapy
pd-l1
title Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
title_full Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
title_fullStr Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
title_full_unstemmed Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
title_short Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
title_sort immunohistochemical expression of pd l1 in esophageal carcinoma and its correlation with histopathological features
topic esophageal carcinoma
immunohistochemistry
immunotherapy
pd-l1
url https://www.nepjol.info/index.php/JPN/article/view/56916
work_keys_str_mv AT tarunpreetsaini immunohistochemicalexpressionofpdl1inesophagealcarcinomaanditscorrelationwithhistopathologicalfeatures
AT manishasharma immunohistochemicalexpressionofpdl1inesophagealcarcinomaanditscorrelationwithhistopathologicalfeatures